Leiderman Elisabeth
Insider CIK 1842133 · BLUE Director · DBTX Chief Financial Officer · AUTL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics plc | A Award deriv | 2026-06-29 | 2026-07-01 | 47,500 | — | $0 | 47,500 | SEC↗ |
| AUTL Autolus Therapeutics plc | A Award deriv | 2026-06-29 | 2026-07-01 | 31,667 | — | $0 | 31,667 | SEC↗ |
| BLUE bluebird bio, Inc. | D To issuer | 2025-06-02 | 2025-06-03 | 1,245 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | U Tender | 2025-05-30 | 2025-06-03 | 1,112 | — | $0 | 1,245 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 47,156 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2023-06-16 | 2023-06-20 | 21,600 | — | $0 | 21,600 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2023-06-16 | 2023-06-20 | 10,790 | — | $0 | 22,256 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2022-10-17 | 2023-03-09 | 1,004 | $6.46 | $6.5K | 11,466 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2022-06-22 | 2022-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2022-06-22 | 2022-06-23 | 3,109 | — | $0 | 12,470 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award deriv | 2022-02-25 | 2022-02-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| BLUE bluebird bio, Inc. | D To issuer deriv | 2021-11-11 | 2021-11-16 | 15,057 | — | $0 | 15,057 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2021-11-11 | 2021-11-16 | 9,361 | — | $0 | 9,361 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2021-10-15 | 2021-10-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2021-10-15 | 2021-10-19 | 4,663 | — | $0 | 4,663 | SEC↗ |